Treatment of endotoxemic mice with anti-interleukin-6 antibody paradoxically increases interleukin-6 levels and stimulates mucosal protein synthesis

Archives of Surgery

Volumn 132, Issue 1, 1997, Pages 82-88

  Wang, Quan ^a   Fischer, Josef E ^a   Hasselgren, Per Olof ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; ENDOTOXEMIA; INTESTINE MUCOSA; JEJUNUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0031032016     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430250084018     Document Type: Article

References (29)

1. Von Allmen D, Hasselgren PO, Higashiguchi T, Frederick J, Zamir O, Fischer JE. Increased intestinal protein synthesis during sepsis and following the administration of tumor necrosis factor α or interleukin-1α. Biochem J. 1992; 286:585-589.
2. Higashiguchi T, Noguchi Y, O'Brien W, Wagner K, Fischer JE, Hasselgren PO. Effect of sepsis on mucosal protein synthesis in different parts of the gastrointestinal tract in rats. Clin Sci. 1994;87:207-211.
3. Wilmore DW, Smith R, O'Dwyer S, Jacobs D, Ziegler T, Wang XD. The gut: a central organ after surgical stress. Surgery. 1988;104:917-923.
4. Garlick PJ. Protein turnover in the whole animal and specific tissues. In: Florkin M, Neuberger A, eds. Comprehensive Biochemistry: Protein Metabolism. Amsterdam, the Netherlands: Elsevier Science Publishers; 1980:77-152.
5. Higashiguchi T, Noguchi Y, Noffsinger A, Fischer JE, Hasselgren PO. Sepsis increases production of total secreted proteins, vasoactive intestinal peptide and peptide YY in isolated rat enterocytes. Am J Surg. 1994;168:251-256.
6. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem. 1993;268:14116-14124.
7. Mester M, Tomkins RG, Gelfand JA, et al. Intestinal production of interleukin-1α during endotoxemia in the mouse. J Surg Res. 1993;54:584-591.
8. Meyer TA, Wang J, Tiao GM, et al. Sepsis and endotoxemia stimulate intestinal interleukin-6 production. Surgery. 1995;118:336-342.
9. Heinrich PC, Castell JV, Anders T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621-636.
10. Zamir O, Hasselgren PO, Kunkel SL, Frederick J, Higashiguchi T, Fischer JE. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg. 1992;127:170-174.
11. Zamir O, Hasselgren PO, von Allmen D, Fischer JE. In vivo administration of interleukin-1α induces muscle proteolysis in normal and adrenalectomized rats. Metabolism. 1993;42:204-208.
12. McNurlan MA, Tomkins AM, Garlick PJ. The effect of starvation on the rate of protein synthesis in rat liver and small intestine. Biochem J. 1979;178:373-379.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem. 1951;193:265-275.
14. Heremans H, Dillen C, Put W, van Damme J, Billiau A. Protective effect of anti-interleukin (IL)-6 antibody against endotoxin associated with paradoxically increased IL-6 levels. Eur J Immunol. 1992;22:2395-2401.
15. Lu ZY, Brochier J, Wijedenes J, Brailly H, Bataille R, Klein B. High amounts of circulating interleukin-6 (IL-6) in the form of monomeric immune complexes during anti-IL-6 therapy. Eur J Immunol. 1992;22:2819-2824.
16. May LT, Neta R, Moldawer LL, Kenney JS, Patel K, Sehgal PB. Antibodies chaperone circulating IL-6: paradoxical effects of anti-IL-6 'neutralizing' antibodies in vivo. J Immunol. 1993;151:3225-3236.
17. Goodman MN. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med. 1994;205:182-185.
18. Garcia-Martinez C, Lopez-Soriano FG, Argiles JM. Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Lett. 1994;76:1-4.
19. 2. Arch Surg. 1994;129:1290-1295.
20. Meyer TA, Tiao GM, James JH, et al. Nitric oxide inhibits LPS-induced IL-6 production in enterocytes. J Surg Res. 1995;58:570-575.
21. Gwosdow AR, Kumar ASR, Bode HH. Interleukin-1 stimulation of the hypothalamic-pituitary-adrenal axis. Am J Physiol. 1990;258:E65-E70.
22. Zamir O, Hasselgren PO, Higashiguchi T, Frederick JA, Fischer JE. Tumor necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediat Inflam. 1992;1:247-250.
23. Tiao G, Fagan JM, Samuels N, et al. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest. 1994;94:2255-2264.
24. Tiao G, Fagan J, Roegner V, et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest. 1996; 97:339-348.
25. Plumley DA, Souba WW, Hautamaki RD, et al. Accelerated lung amino acid release in hyperdynamic septic surgical patients. Arch Surg. 1990;125:57-61.
26. Pedersen P, Säljö A, Hasselgren PO. Protein and energy metabolism in liver tissue following intravenous infusion of live E. coli bacteria in rats. Circ Shock. 1987;21:59-64.
27. Rafferty JF, Noguchi Y, Fischer JE, Hasselgren PO. Sepsis in rats stimulates cellular proliferation in the mucosa of the small intestine. Gastroenterology. 1994;107:121-127.
28. Starnes HF, Pearce MK, Tenari A, Yim JH, Zou JC, Abrams J. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal TNF challenge in mice. J Immunol. 1990;145:4185-4191.
29. Fischer JE, Hasselgren PO. Cytokines and glucocorticoids in the regulation of the 'hepato-skeletal muscle axis' in sepsis. Am J Surg. 1991;161:266-271.